Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.

AIMS Diet-induced obesity is associated with increased myocardial fatty acid (FA) utilization, insulin resistance, and cardiac dysfunction. The study was designed to test the hypothesis that impaired glucose utilization accounts for initial changes in FA metabolism. METHODS AND RESULTS Ten-week-old C57BL6J mice were fed a high-fat diet (HFD, 45% calories from fat) or normal chow (4% calories from fat). Cardiac function and substrate metabolism in isolated working hearts, glucose uptake in isolated cardiomyocytes, mitochondrial function, insulin-stimulated protein kinase B (Akt/PKB) and Akt substrate (AS-160) phosphorylation, glucose transporter 4 (GLUT4) translocation, pyruvate dehydrogenase (PDH) activity, and mRNA levels for metabolic genes were determined after 2 or 5 weeks of HFD. Two weeks of HFD reduced basal rates of glycolysis and glucose oxidation and prevented insulin stimulation of glycolysis in hearts and reduced insulin-stimulated glucose uptake in cardiomyocytes. Insulin-stimulated Akt/PKB and AS-160 phosphorylation were preserved, and PDH activity was unchanged. GLUT4 content was reduced by 55% and GLUT4 translocation was significantly attenuated. HFD increased FA oxidation rates and myocardial oxygen consumption (MVO2), which could not be accounted for by mitochondrial uncoupling or by increased expression of peroxisome proliferator activated receptor-alpha (PPAR-alpha) target genes, which increased only after 5 weeks of HFD. CONCLUSION Rates of myocardial glucose utilization are altered early in the course of HFD because of reduced GLUT4 content and GLUT4 translocation despite normal insulin signalling to Akt/PKB and AS-160. The reciprocal increase in FA utilization is not due to PPAR-alpha-mediated signalling or mitochondrial uncoupling. Thus, the initial increase in myocardial FA utilization in response to HFD likely results from impaired glucose transport that precedes impaired insulin signalling.

[1]  David E James,et al.  IRS1-independent defects define major nodes of insulin resistance. , 2008, Cell metabolism.

[2]  J. S. Elmendorf,et al.  Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance. , 2008, Molecular endocrinology.

[3]  G. Sweeney,et al.  Cardiac remodeling in obesity. , 2008, Physiological reviews.

[4]  David E James,et al.  The GLUT4 code. , 2008, Molecular endocrinology.

[5]  E. Abel,et al.  Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. , 2008, Clinical science.

[6]  M. Birnbaum,et al.  A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. , 2007, Cell metabolism.

[7]  Xiaoming Sheng,et al.  Mitochondrial Energetics in the Heart in Obesity-Related Diabetes , 2007, Diabetes.

[8]  D. Ouwens,et al.  Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification , 2007, Diabetologia.

[9]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[10]  Ahmad Y. Sheikh,et al.  Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. , 2007, American journal of physiology. Heart and circulatory physiology.

[11]  E. Abel,et al.  Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. , 2006, Physiology.

[12]  J. S. Elmendorf,et al.  Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport. , 2006, American journal of physiology. Cell physiology.

[13]  J. Dyck,et al.  Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. , 2006, American journal of physiology. Heart and circulatory physiology.

[14]  R. Cooksey,et al.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. , 2005, Endocrinology.

[15]  B. Rothermel,et al.  Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. , 2005, Diabetes.

[16]  E. Abel,et al.  Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity , 2005, Circulation.

[17]  M. Lazar,et al.  Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action* , 2005, Journal of Biological Chemistry.

[18]  E. Abel.  Myocardial insulin resistance and cardiac complications of diabetes. , 2005, Current drug targets. Immune, endocrine and metabolic disorders.

[19]  R. Heine,et al.  Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats , 2005, Diabetologia.

[20]  E. Abel,et al.  Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.

[21]  D. Severson.  Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. , 2004, Canadian journal of physiology and pharmacology.

[22]  K. Kandror,et al.  Regulation of insulin-responsive aminopeptidase expression and targeting in the insulin-responsive vesicle compartment of glucose transporter isoform 4-deficient cardiomyocytes. , 2004, Molecular endocrinology.

[23]  A. Strawbridge,et al.  Disruption of Cortical Actin in Skeletal Muscle Demonstrates an Essential Role of the Cytoskeleton in Glucose Transporter 4 Translocation in Insulin-sensitive Tissues* , 2004, Journal of Biological Chemistry.

[24]  R. Cooksey,et al.  Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.

[25]  A. Bonen,et al.  Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. , 2004, Diabetes.

[26]  C. Dence,et al.  Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women , 2004, Circulation.

[27]  C. Riganti,et al.  Insulin Stimulates Glucose Transport Via Nitric Oxide/Cyclic GMP Pathway in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Isabel R Schlaepfer,et al.  Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance Published, JLR Papers in Press, April 16, 2003. DOI 10.1194/jlr.M300003-JLR200 , 2003, Journal of Lipid Research.

[29]  M. Holness,et al.  Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. , 2003, American journal of physiology. Endocrinology and metabolism.

[30]  M. Capecchi,et al.  An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. , 2002, Development.

[31]  D. Kelly,et al.  Peroxisome Proliferator-activated Receptor α (PPARα) Signaling in the Gene Regulatory Control of Energy Metabolism in the Normal and Diseased Heart , 2002 .

[32]  D. Severson,et al.  Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. , 2002, American journal of physiology. Heart and circulatory physiology.

[33]  J. Chatham,et al.  Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. , 2002, Cardiovascular research.

[34]  C. Kahn,et al.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. , 2002, The Journal of clinical investigation.

[35]  G. Heigenhauser,et al.  Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet. , 2001, American journal of physiology. Endocrinology and metabolism.

[36]  R. Tian,et al.  Responses of GLUT4-Deficient Hearts to Ischemia Underscore the Importance of Glycolysis , 2001, Circulation.

[37]  B. Lowell,et al.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. , 1999, The Journal of clinical investigation.

[38]  M. Holness,et al.  Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase: regulation by insulin, cyclic AMP and pyruvate. , 1997, Journal of molecular and cellular cardiology.

[39]  G. Shulman,et al.  Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. , 1997, Circulation.

[40]  G. Heigenhauser,et al.  Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. , 1996, The American journal of physiology.

[41]  M. Holness,et al.  The long-term regulation of skeletal muscle pyruvate dehydrogenase kinase by dietary lipid is dependent on fatty acid composition. , 1995, European journal of biochemistry.

[42]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[43]  O. Mjøs.  Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. , 1971, The Journal of clinical investigation.

[44]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[45]  A. Luchner,et al.  Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[46]  E. Abel,et al.  Glucose transport in the heart. , 2004, Frontiers in bioscience : a journal and virtual library.

[47]  Abel Ed,et al.  Glucose transport in the heart , 2004 .

[48]  D. Kelly,et al.  Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. , 2002, Journal of molecular and cellular cardiology.

[49]  Robert A. Harris,et al.  Regulation of the activity of the pyruvate dehydrogenase complex. , 2002, Advances in enzyme regulation.

[50]  N. Cornell,et al.  Determination of short-chain coenzyme A compounds by reversed-phase high-performance liquid chromatography. , 1988, Methods in enzymology.